LobbyingAgile Therapeutics lobbying by quarter
Agile Therapeutics's latest lobbying report covers Q4 2024, at $45K. Its first report covers Q4 2022; the issues it reports most are Health Issues.
Agile Therapeutics
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $45K | 1 |
| Q1 2023 | $45K | 1 |
| Q2 2023 | $45K | 1 |
| Q3 2023 | $45K | 1 |
| Q4 2023 | $45K | 1 |
| Q1 2024 | $45K | 1 |
| Q2 2024 | $45K | 1 |
| Q3 2024 | $30K | 1 |
| Q4 2024 | $45K | 1 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$390K · 9 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Health & Human Services, Dept of (HHS)9 reports
- HOUSE OF REPRESENTATIVES9 reports
- Labor, Dept of (DOL)9 reports
- SENATE9 reports
- Treasury, Dept of9 reports
Firms it paid
| Firm | ||
|---|---|---|
| Keefe Strategies LLC Fka Keefe Singiser Partners | $390K | 9 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| DANA SINGISER | Special Assistant to the President, The White House; Staff Director, Senate Democratic Steering and Outreach Committee | Q4 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/04/09for Q4 2024 | Keefe Strategies LLC Fka Keefe Singiser Partners | $45K |
| 25/01/18for Q4 2024 | Keefe Strategies LLC Fka Keefe Singiser Partners | $45K |
| 24/10/15for Q3 2024 | Keefe Strategies LLC Fka Keefe Singiser Partners | $30K |
| 24/10/12for Q3 2024 | Keefe Strategies LLC Fka Keefe Singiser Partners | $45K |
| 24/06/28for Q2 2024 | Keefe Strategies LLC Fka Keefe Singiser Partners | $45K |
| 24/04/12for Q1 2024 | Keefe Strategies LLC Fka Keefe Singiser Partners | $45K |
| 24/01/16for Q4 2023 | Keefe Strategies LLC Fka Keefe Singiser Partners | $45K |
| 23/10/18for Q3 2023 | Keefe Strategies LLC Fka Keefe Singiser Partners | $45K |
| 23/07/17for Q2 2023 | Keefe Strategies LLC Fka Keefe Singiser Partners | $45K |
| 23/04/17for Q1 2023 | Keefe Strategies LLC Fka Keefe Singiser Partners | $45K |
| 23/01/19for Q4 2022 | Keefe Strategies LLC Fka Keefe Singiser Partners | $45K |